Citigroup
GH icon

Citigroup’s Guardant Health GH Stock Holding History

Citigroup’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-147,600
Closed -$3.04M – 5653
2024
Q1 		$3.04M Buy
+147,600
New +$3.16M ﹤0.01% 2075
2023
Q1 		– Sell
-70,000
Closed -$1.9M – 5630
2022
Q4 		$1.9M Sell
70,000
-49,900
-42% -$2.28M ﹤0.01% 2077
2022
Q3 		$6.45M Buy
119,900
+55,600
+86% +$2.85M ﹤0.01% 1395
2022
Q2 		$2.59M Buy
+64,300
New +$3.19M ﹤0.01% 1926
2019
Q4 		– Sell
-20,400
Closed -$1.3M – 7720
2019
Q3 		$1.3M Buy
+20,400
New +$1.8M ﹤0.01% 3339

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citigroup's GH Position: Q1 2026 in Review

Citigroup reduced its Guardant Health (GH) stake by 7.8% in Q1 2026, selling an estimated $1.49M and leaving 174,072 shares worth $16.1M. The position accounts for 0.01% of the portfolio, ranked #1194.

Citigroup first reported a position in GH in Q4 2018 and has held it in 30 quarters since. The position peaked at $19.3M in Q4 2025. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Citigroup held 174,072 shares of Guardant Health worth $16.1M as of Q1 2026.
  • Citigroup sold 14,816 Guardant Health shares in Q1 2026, an estimated $1.49M.
  • Guardant Health made up 0.01% of Citigroup's portfolio in Q1 2026, its #1194 holding.
  • Citigroup first reported a position in Guardant Health in Q4 2018 and has held it in 30 quarters since.
  • Citigroup's Guardant Health position peaked at $19.3M in Q4 2025.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.